2.80
0.00 (0.00%)
| Penutupan Terdahulu | 2.80 |
| Jumlah Dagangan | 169,557 |
| Harga / Buku (P/B) | 0.960 |
| Julat 52 Minggu |
| EPS Cair (TTM) | 7.71 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 35.56% |
| Nisbah Semasa (MRQ) | 22.15 |
| Aliran Tunai Operasi (OCF TTM) | -59.59 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -37.34 M |
| Pulangan Atas Aset (ROA TTM) | -29.89% |
| Pulangan Atas Ekuiti (ROE TTM) | -54.06% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Boundless Bio, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -0.5 |
| Purata | -0.50 |
|
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 11.40% |
| % Dimiliki oleh Institusi | 70.35% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Arch Venture Management, Llc | 30 Jun 2026 | 2,694,095 |
| Adar1 Capital Management, Llc | 30 Jun 2026 | 1,968,216 |
| Affinity Asset Advisors, Llc | 30 Jun 2026 | 250,000 |
| Ensign Peak Advisors, Inc | 30 Jun 2026 | 159,835 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |